Results of a Randomized Phase II Study of Oral Sapacitabine in Elderly Patients with Previously Untreated or First Relapsed Acute Myeloid Leukemia

PURPOSE: Current treatment of acute myeloid leukemia (AML) is not adequate for most elderly patients. This is the first part of an ongoing study of AML and myelodysplastic syndromes (MDS) and evaluated the efficacy and toxicity of sapacitabine, a novel oral cytosine nucleoside analog, in previously...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kantarjian, Hagop, Faderl, Stefan, Garcia-Manero, Guillermo, Luger, Selina, Venugopal, Parameswaran, Maness, Lori, Wetzler, Meir, Coutre, Steven, Stock, Wendy, Claxton, David, Goldberg, Stuart L., Arellano, Martha, Strickland, Stephen A., Seiter, Karen, Schiller, Gary, Jabbour, Elias, Chiao, Judy, Plunkett, William
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4004358/
https://ncbi.nlm.nih.gov/pubmed/23075701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(12)70436-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados